<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>染色粉状有靶向Delta / India Variant的抗体水平较低 Pfizer vaccinated have lower antibody levels targeting the Delta/India variant</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script>
<script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">Pfizer vaccinated have lower antibody levels targeting the Delta/India variant<br/>染色粉状有靶向Delta / India Variant的抗体水平较低 </h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2021-06-06 15:12:02</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2021/6/c6cd3ccd08bb1c15c1500379f1715971.png"><img src="http://img2.diglog.com/img/2021/6/c6cd3ccd08bb1c15c1500379f1715971.png" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are on average lower than those against previously circulating variants in the UK, according to new laboratory data from the Francis Crick Institute and the  National Institute for Health Research (NIHR) UCLH Biomedical Research Centre, published today (Thursday) as a Research letter in   The Lancet.</p><p>疫苗的疫苗中的抗体水平能够识别和抗击印度首次发现的新SARS-COV-2 Delta Variant（B.1.617.2）平均低于英国先前循环变体的血液（B.1.617.2），根据Francis Crick Institute和国家卫生研究所（NIHR）UCLH生物医学研究中心的新实验室数据，今天（星期四）出版作为柳叶刀的研究信。</p><p> The results also show that levels of these antibodies are lower with increasing age and that levels decline over time, providing additional evidence in support of plans to deliver a vaccination boost to vulnerable people in the Autumn.</p><p> 结果还表明，随着年龄的增加，随着年龄的增加，这些抗体的水平较低，随着时间的推移，该水平下降，提供了额外的证据，以支持在秋季提供疫苗接种疫苗的疫情。</p><p> And, the researchers support current plans to reduce the dose gap between vaccines since they found that after just one dose of the Pfizer-BioNTech vaccine, people are less likely to develop antibody levels against the B.1.617.2 (Delta) variant as high as those seen against the previously dominant B.1.1.7 (Alpha) variant, first found in Kent.</p><p> 而且，研究人员支持目前的计划，以减少疫苗之间的剂量差距，因为它们发现在一剂辉瑞 - 生物疫苗之后，人们不太可能发展抗体水平，而不是B.1.617.2（Delta）变体高作为针对以前占优势的B.1.1.7（α）变体的那些，首先在肯特发现。</p><p> This work is a powerful example of effective collaborations between NHS and academic colleagues, that can help us to navigate changes in this new phase of the pandemic.</p><p> 这项工作是NHS和学术同事之间有效合作的强大示例，可以帮助我们在这一新阶段导航变化。</p><p> Although laboratory results such as these are needed to provide a guide as to how the virus might be evolving to escape the first generation of vaccines, levels of antibodies alone do not predict vaccine effectiveness and prospective population studies are also needed. Lower neutralising antibody levels may still be associated with protection against COVID-19.</p><p> 虽然需要这些结果，但需要提供关于病毒如何发展的指导，以逃避第一代疫苗，抗体的水平不预测疫苗效果，也需要预期的人口研究。较低中和抗体水平仍可能与对Covid-19的保护有关。</p><p> This is the largest study published to date investigating vaccine-induced antibody neutralising capacity against the newest variants of concern in healthy adults. Researchers have submitted their findings to the Genotype-to-Phenotype National Virology Consortium (G2P-UK), the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) and the Joint Committee on Vaccination and Immunisation (JCVI), as evidence of the level of protection people might receive against the new variants after one dose and both doses of the Pfizer COVID-19 vaccine.</p><p> 这是迄今为止迄今为止调查疫苗诱导的抗体中和能力的最大的研究，这对于健康成人的最新变异性。研究人员已经向基因型对表型国家病毒学联盟（G2P-UK），新兴呼吸道病毒威胁咨询小组（神经创造）和接种疫苗联合委员会（JCVI）以及疫苗接种委员会（JCVI）的结果提交了调查结果，作为水平的证据保护人们可能会在一剂和两剂量的辉瑞Covid-19疫苗后接受新变种。</p><p> As part of the SARS-CoV-2 Legacy study, led by the Crick and partners at  UCL and  University College London Hospitals NHS Foundation Trust (UCLH), healthcare workers and staff from the institutions have been donating regular blood and swab samples so that researchers can track changing risk of infection and response to vaccination.</p><p> 作为SARS-COV-2遗留研究的一部分，由伦敦驻伦敦医院的克里克和大学学院的Crick和合作伙伴NHS基金会信托（UCLH），机构的医疗工作者和工作人员一直捐赠血液和拭子样本，以便研究人员可以跟踪不断变化的感染风险和对疫苗接种的反应。 </p><p> Thanks to samples of the latest variants of concern being provided by NHS labs to the G2P-UK consortium, researchers have been able to quickly assess the potential risks they might pose.</p><p>由于NHS实验室向G2P-UK联盟提供的最新变体的样本，研究人员能够快速评估他们可能姿势的潜在风险。</p><p> Within just a few days of having enough of each variant to study, they were able to analyse antibodies in the blood of 250 healthy people who received either one or two doses of the Pfizer-BioNTech Covid-19 vaccine, up to three months after their first dose. Using a new highly accurate high throughput viral neutralisation assay developed at the Crick, they tested the ability of antibodies to block entry of the virus into cells, so called ‘neutralising antibodies’, against five different variants of SARS-CoV-2:</p><p> 在几天内有足够的每种变体学习，他们能够分析250名健康人的血液中的抗体，他们接受一两剂的辉瑞 -  Biontech Covid-19疫苗，最长可达三个月第一剂。在克里克开发的新高精度高通量病毒中和测定，它们测试了抗体阻断病毒进入细胞的能力，所以称为“中和抗体”，对抗五种不同的SARS-COV-2变体：</p><p>  They then compared concentrations of these neutralising antibodies between all variants. Data from previous clinical studies suggests that higher antibody titres (the greatest dilution level that still blocks 50% of virus infection in the lab) is a good predictor of vaccine efficacy and greater protection against COVID-19.</p><p>  然后将它们与所有变体之间的浓度进行比较这些中和抗体。来自先前临床研究的数据表明，抗体滴度更高（仍然阻塞实验室中50％的病毒感染的最大稀释水平）是疫苗疗效的良好预测因子，更加抗Covid-19。</p><p> They found that in people who had been fully vaccinated with two doses of the Pfizer-BioNTech vaccine, levels of neutralising antibodies were more than five times lower* against the B.1.617.2 variant when compared to the original strain, upon which current vaccines are based.</p><p> 他们发现，在用两种剂量的辉瑞生物疫苗接种的人中，与原始菌株相比，中和抗体的中和抗体的水平较低，抗B.1.617.2变体。当前疫苗基于。</p><p> Importantly, this antibody response was even lower in people who had only received one dose. After a single dose of Pfizer-BioNTech, 79% of people had a quantifiable neutralising antibody response against the original strain, but this fell to 50% for B.1.1.7, 32% for B.1.617.2 and 25% for B.1.351.</p><p> 重要的是，这种抗体反应甚至在只接受一次剂量的人中甚至更低。在单一剂量的Pfizer-Biontech之后，79％的人对原始菌株进行了可量化的中和抗体反应，但B.1.1.7的50％达到50％，B.1.617.2和25％的B.1.1.7和25％跌至50％。 .1.351。</p><p> While antibody levels decreased with age against all variants, no correlation was observed for sex or BMI.</p><p> 虽然抗体水平随着AGE的年龄而降低，但对于性或BMI没有观察到相关性。</p><p>  The study participants analysed here had all been vaccinated with the Pfizer-BioNTech vaccine. More work is underway to test neutralising antibodies against these same variants in people who have been vaccinated with the Oxford/AstraZeneca vaccine.</p><p>  这里分析的研究参与者全部​​与辉瑞疫苗接种疫苗接种疫苗。正在进行更多的工作来测试与已接种牛津/阿斯塔尼卡疫苗接种疫苗的人中相同的抗体的中和抗体。 </p><p> Emma Wall, UCLH Infectious Diseases consultant and Senior Clinical Research Fellow for the Legacy study, said: “This virus will likely be around for some time to come, so we need to remain agile and vigilant. Our study is designed to be responsive to shifts in the pandemic so that we can quickly provide evidence on changing risk and protection.</p><p>艾玛墙，UCLH传染病顾问和高级临床研究员的遗产研究，说：“这种病毒可能会在一段时间内到来，所以我们需要保持敏捷和警惕。我们的研究旨在响应于大流行的转变，以便我们能够快速提供改变风险和保护的证据。</p><p> “The most important thing is to ensure that vaccine protection remains high enough to keep as many people out of hospital as possible. And our results suggest that the best way to do this is to quickly deliver second doses and provide boosters to those whose immunity may not be high enough against these new variants.”</p><p> “最重要的是确保疫苗保护仍然足够高，以便尽可能多地留出医院。我们的结果表明，这样做的最佳方法是快速提供第二剂量，并为那些对这些新变种的免疫力不足以足够高的人提供助推器。“</p><p> David LV Bauer, group leader of the Crick’s  RNA Virus Replication Laboratory and member of the G2P-UK National Virology Consortium, said: “New variants occur naturally and those that have an advantage will spread. We now have the ability to quickly adapt our vaccination strategies to maximise protection where we know people are most vulnerable.</p><p> David Lv Bauer，Crick的RNA病毒复制实验室的集团负责人和G2P-UK国家病毒学联盟的成员表示：“新的变体自然地发生，并且具有优势的人将传播。我们现在有能力快速调整我们的疫苗接种策略，以最大限度地保护我们认识人们最脆弱的保护。</p><p> “Keeping track of these evolutionary changes is essential for us to retain control over the pandemic and return to normality. This work is a powerful example of effective collaborations between NHS and academic colleagues, that can help us to navigate changes in this new phase of the pandemic.”</p><p> “跟踪这些进化的变化对于我们来说是必不可少的，让我们保持对大流行并恢复正常性的控制。这项工作是NHS和学术同事之间有效合作的强大示例，可以帮助我们在这一新阶段导航变化。“</p><p> Join our mailing lists to receive updates about our latest research and to hear about our free public events and exhibitions.  If you would like to find out more about how we manage your personal information please see our  privacy policy.</p><p> 加入我们的邮件列表，以获得有关最新研究的更新，并听取我们的免费公共活动和展览。如果您想了解更多关于我们如何管理您的个人信息，请参阅我们的隐私政策。 </p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://www.crick.ac.uk/news/2021-06-03_pfizer-biontech-vaccine-recipients-have-lower-antibody-levels-targeting-the-delta-variant-first-discovered-in-india">https://www.crick.ac.uk/news/2021-06-03_pfizer-biontech-vaccine-recipients-have-lower-antibody-levels-targeting-the-delta-variant-first-discovered-in-india</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/粉状/">#粉状</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/疫苗/">#疫苗</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/谷歌/">#谷歌</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy;2012-2021 diglog.com </div></div></body></html>